Search

everythinglearnresearchcommunity

for

Search:↓

A woman with complete hair loss and severe hyperthyroidism was successfully treated with azathioprine and hydroxychloroquine.

ILC1 cells contribute to hair loss in alopecia areata.

A woman developed facial hair cysts after using a 3% minoxidil solution for hair loss, which disappeared after stopping the treatment and removing the cysts surgically.

A woman with severe hair loss regrew mostly white hair after treatment.

Hair color is not a risk factor for developing alopecia areata.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Lupus can cause hair loss and nail changes, with treatments available for both.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

People with early graying hair often have lower levels of iron, ferritin, and calcium.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

N-acetyl-cysteine shows promise in treating various diseases and may improve skin and hair conditions, but more research is needed on dosages and long-term effects.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Two patients developed complete hair loss after Alemtuzumab treatment for MS, with no regrowth after two years.

The document describes various skin conditions, their features, and treatments but lacks detailed study size information.

Gray hair can potentially be reversed, leading to new treatments.

Red and infrared light therapy improves hair growth in balding patients.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

The document says a skin condition called alopecia areata causes hair loss and stress, and is treated with strong skin creams, injections, or other therapies, but treatment success varies.

FAGA shows varied hair thickness, while TE has more empty follicles.

Psoriasis patients are more likely to develop alopecia areata due to complex autoimmune interactions.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Calcipotriol's effectiveness for treating alopecia areata is unclear and needs more research.

Siddha medicine can effectively treat Alopecia areata, leading to significant hair regrowth.